Age-related macular degeneration and its  possible prevention

Marc M Cohen

School of Health Sciences, RMIT University, PO Box 71, Bundoora, VIC 3083; and President, Australasian Integrative Medicine Association.

Correspondence: marc.cohen@rmit.edu.au

Competing interests:

The author has given occasional paid lectures for companies that market carotenoid-containing products.

1. Constable IJ. Age-related macular degeneration and its possible prevention. Med J Aust 2004; 181: 471-472. <eMJA full text>
2. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Ophthalmol 2001; 119: 1417-1436.
3. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004; 75: 216-230.
4. Olmedilla B, Granado F, Blanco I, Vaquero M. Lutein, but not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study. Nutrition 2003; 19: 21-24.
5. Koh H-H, Murray IJ, Nolan D, et al. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res 2004; 79: 21-27.
6. Alves-Rodrigues A, Shao A. The science behind lutein. Toxicol Lett 2004; 150: 57-83.

Online responses are no longer available. Please refer to our instructions for authors page for more information.